{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Trazodone Hydrochloride is a prescription antidepressant medication used to treat major depressive disorder. It works by increasing serotonin levels in the brain to improve mood and sleep. Available as oral tablets in strengths of 50mg, 100mg, 150mg, and 300mg, manufactured by Torrent Pharmaceuticals Limited under ANDA202180. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Trazodone hydrochloride \u2014 ANDA 071258 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071258", "mediaType": "text/html", "title": "Trazodone hydrochloride"}], "identifier": "ANDA071258", "issued": "2016-09-16", "keyword": ["drug", "drug-safety", "medications", "fda", "drug-manufacturers"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Trazodone hydrochloride"}